Literature DB >> 19712708

To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition.

Jennifer A Jacobsen1, Jody L Major Jourden, Melissa T Miller, Seth M Cohen.   

Abstract

This short review highlights some recent advances in matrix metalloproteinase inhibitor (MMPi) design and development. Three distinct approaches to improved MMP inhibition are discussed: (1) the identification and investigation of novel zinc-binding groups (ZBGs), (2) the study of non-zinc-binding MMPi, and (3) mechanism-based MMPi that form covalent adducts with the protein. Each of these strategies is discussed and their respective advantages and remaining challenges are highlighted. The studies discussed here bode well for the development of ever more selective, potent, and well-tolerated MMPi for treating several important disease pathologies. Copyright 2009 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2009        PMID: 19712708     DOI: 10.1016/j.bbamcr.2009.08.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  87 in total

1.  Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex.

Authors:  Allison S Harney; Laura B Sole; Thomas J Meade
Journal:  J Biol Inorg Chem       Date:  2012-05-22       Impact factor: 3.358

Review 2.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

3.  Screening Identifies Thimerosal as a Selective Inhibitor of Endoplasmic Reticulum Aminopeptidase 1.

Authors:  Athanasios Stamogiannos; Athanasios Papakyriakou; Francois-Xavier Mauvais; Peter van Endert; Efstratios Stratikos
Journal:  ACS Med Chem Lett       Date:  2016-05-31       Impact factor: 4.345

Review 4.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

Review 5.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

6.  Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Authors:  Jennifer A Jacobsen; Jessica L Fullagar; Melissa T Miller; Seth M Cohen
Journal:  J Med Chem       Date:  2010-12-28       Impact factor: 7.446

7.  Potent inhibition of dinuclear zinc(II) peptidase, an aminopeptidase from Aeromonas proteolytica, by 8-quinolinol derivatives: inhibitor design based on Zn2+ fluorophores, kinetic, and X-ray crystallographic study.

Authors:  Kengo Hanaya; Miho Suetsugu; Shinya Saijo; Ichiro Yamato; Shin Aoki
Journal:  J Biol Inorg Chem       Date:  2012-02-05       Impact factor: 3.358

Review 8.  Key metalloproteinase-mediated pathways in the kidney.

Authors:  Tammo Ostendorf; Andreas Ludwig; Justyna Wozniak; Jürgen Floege
Journal:  Nat Rev Nephrol       Date:  2021-04-20       Impact factor: 28.314

9.  Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.

Authors:  Joshua Roth; Dmitriy Minond; Etzer Darout; Qin Liu; Janelle Lauer; Peter Hodder; Gregg B Fields; William R Roush
Journal:  Bioorg Med Chem Lett       Date:  2011-09-22       Impact factor: 2.823

10.  Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis.

Authors:  Sarah J Atkinson; Meghan Nolan; Lindsey Klingbeil; Kelli Harmon; Patrick Lahni; Basilia Zingarelli; Hector R Wong
Journal:  Crit Care Med       Date:  2016-04       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.